Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Azelaprag [inn]
2. 4b8rej8zgy
3. Unii-4b8rej8zgy
4. 2049980-18-7
5. Amg 986
6. 2-pyrimidineethanesulfonamide, N-(4-(2,6-dimethoxyphenyl)-5-(5-methyl-3-pyridinyl)-4h-1,2,4-triazol-3-yl)-alpha,beta,5-trimethyl-, (alphas,betar)-
7. Amg986
8. Chembl4866732
9. Schembl18247065
10. Gtpl10061
11. Amg-986
12. Bdbm363380
13. Akos040741204
14. Us9845310, Example 506.0
15. Example 263 [wo2016187308a1]
16. Hy-109111
17. Cs-0077720
18. (2s,3r)-n-(4-(2,6-dimethoxyphenyl)-5-(5-methyl-3-pyridinyl)-4h-1,2,4-triazol-3-yl)-3-(5-methyl-2-pyrazinyl)-2-butanesulfonamide
19. (2s,3r)-n-[4-(2,6-dimethoxyphenyl)-5-(5-methylpyridin-3-yl)-1,2,4-triazol-3-yl]-3-(5-methylpyrimidin-2-yl)butane-2-sulfonamide
20. 2-pyrimidineethanesulfonamide, N-(4-(2,6-dimethoxyphenyl)-5-(5-methyl-3-pyridinyl)-4h-1,2,4-triazol-3-yl)-.alpha.,.beta.,5-trimethyl-, (.alpha.s,.beta.r)-
| Molecular Weight | 523.6 g/mol |
|---|---|
| Molecular Formula | C25H29N7O4S |
| XLogP3 | 2.7 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 9 |
| Exact Mass | g/mol |
| Monoisotopic Mass | g/mol |
| Topological Polar Surface Area | 142 |
| Heavy Atom Count | 37 |
| Formal Charge | 0 |
| Complexity | 810 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
86
PharmaCompass offers a list of Azelaprag API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Azelaprag manufacturer or Azelaprag supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Azelaprag manufacturer or Azelaprag supplier.
PharmaCompass also assists you with knowing the Azelaprag API Price utilized in the formulation of products. Azelaprag API Price is not always fixed or binding as the Azelaprag Price is obtained through a variety of data sources. The Azelaprag Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 2049980-18-7 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 2049980-18-7, including repackagers and relabelers. The FDA regulates 2049980-18-7 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 2049980-18-7 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A 2049980-18-7 supplier is an individual or a company that provides 2049980-18-7 active pharmaceutical ingredient (API) or 2049980-18-7 finished formulations upon request. The 2049980-18-7 suppliers may include 2049980-18-7 API manufacturers, exporters, distributors and traders.
2049980-18-7 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 2049980-18-7 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 2049980-18-7 GMP manufacturer or 2049980-18-7 GMP API supplier for your needs.
A 2049980-18-7 CoA (Certificate of Analysis) is a formal document that attests to 2049980-18-7's compliance with 2049980-18-7 specifications and serves as a tool for batch-level quality control.
2049980-18-7 CoA mostly includes findings from lab analyses of a specific batch. For each 2049980-18-7 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
2049980-18-7 may be tested according to a variety of international standards, such as European Pharmacopoeia (2049980-18-7 EP), 2049980-18-7 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (2049980-18-7 USP).
